Kidney disease biomarker may indicate COPD risk

Image
IANS New York
Last Updated : Sep 28 2018 | 4:41 PM IST

Researchers have found that a commonly used biomarker of kidney disease may also indicate lung problems, particularly chronic obstructive pulmonary disease (COPD).

The study, published in the American Journal of Respiratory and Critical Care Medicine, reported a link between albuminuria -- a condition that indicates the presence of the protein albumin in urine -- and COPD.

According to researchers, albuminuria indicates damage to the single layer of cells lining blood vessels, known as the endothelium, in the kidney.

The findings suggested that for each standard deviation increase in albuminuria, there was a 15 per cent increase in those who developed moderate-to-severe COPD. It also found 26 per cent increase in COPD hospitalisations and deaths.

"The pulmonary microvasculature is critical to gas exchange and known to be impaired in patients with COPD, especially those with emphysema," said co-author Elizabeth C. Oelsner from the Columbia University, US.

"We wanted to test whether albuminuria, a non-invasive and commonly used clinical test, could serve as a marker for increased risk of developing chronic lower respiratory diseases, such as COPD and asthma," Oelsner added.

For the study, the research team pooled information from 31,877 participants with an average age of 60 years from six cohort studies. They excluded participants who had been diagnosed with COPD or asthma upon enrolment in the studies.

The participants were followed for changes in lung function over a median of six years and for respiratory hospitalisations and mortality over a median of 15 years.

The team found a three per cent greater decline in FEV1 (the amount of air that can be forcibly exhaled in one second) and an 11 per cent greater decline in the ratio between FEV1 and FVC (the total amount of air that can be forcibly exhaled after taking the deepest breath possible).

Both FEV1 and FEV1/FVC are important measures of lung function, the researcher said.

The researchers noted that these associations remained significant even after taking into account smoking history, diabetes, hypertension and cardiovascular disease.

--IANS

vc/mag/sed

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 28 2018 | 4:32 PM IST

Next Story